Originally posted by @yeyeneaters on TikTok · 13s|Watch on TikTok

Full video transcriptClick to expand

Auto-generated transcript of @yeyeneaters's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

0:00Guys don't take CGZ 125 or at the moorland if you don't know the side effect
0:05The growing pain in my hands are so bad and my nose is getting bigger and my ears are getting bigger
0:10I don't think I've put enough back water

@yeyeneaters's CJC peptide claims need more context

Name: @yeyeneaters's CJC peptide claims need more context
Uploaded: 2026-02-10T00:13:25.000Z
Duration: 13 s

Yeyeneaters

TikTok creator

111.6K viewsWatch on TikTok →

Quick answer

CJC-1295 stimulates pituitary GH release, driving IGF-1 elevation that can cause soft tissue and cartilage growth in the hands, nose, and ears with prolonged or supraphysiological exposure. The creator's described symptoms are consistent with early acromegaloid changes documented in GH excess literature, though without dose, frequency, or IGF-1 data, the severity and cause cannot be determined. Bacteriostatic water reconstitution errors affect concentration accuracy but do not independently cause systemic GH-driven tissue changes.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Start provider review Browse video library

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 3 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @yeyeneaters's CJC peptide claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

ReviewGrowth-hormone peptide evidence1998

Ipamorelin, the first selective growth hormone secretagogue

Background source for ipamorelin selectivity and GH-secretagogue mechanism.

PubMed

ReviewGrowth-hormone peptide evidence2001

The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation

Preclinical context that should not be overstated as consumer clinical evidence.

PubMed

Video claim decision path

Turn the claim into a safer next question

Direct answer

@yeyeneaters's CJC peptide claims need more context should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Start the provider review

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Helpful context before the funnel

Review method

See how FormBlends checks viral health claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@yeyeneaters's CJC peptide claims need more context" from Yeyeneaters. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: CJC-1295 stimulates pituitary GH release, driving IGF-1 elevation that can cause soft tissue and cartilage growth in the hands, nose, and ears with prolonged or supraphysiological exposure.

The reason this review is not generic is the source wording and the canonical claim label "peptides not a lot of people know about this fyp cjc research gre." In this clip, the useful excerpt is: "Guys don't take CGZ 125 or at the moorland if you don't know the side effect The growing pain in my hands are so bad and my nose is getting bigger and my ears are getting bigger I don't think I've put enough back water" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Chronic IGF-1 excess is the mechanism behind acromegaly, which is clinically characterized by enlarged extremities and facial cartilage changes including the nose and ears, per Melmed (2014, NEJM).

People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].

The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

CJC-1295 stimulates pituitary GH release, driving IGF-1 elevation that can cause soft tissue and cartilage growth in the hands, nose, and ears with prolonged or supraphysiological exposure.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

CJC-1295 stimulates pituitary GH release, driving IGF-1 elevation that can cause soft tissue and cartilage growth in the hands, nose, and ears with prolonged or supraphysiological exposure. The creator's described symptoms are consistent with early acromegaloid changes documented in GH excess literature, though without dose, frequency, or IGF-1 data, the severity and cause cannot be determined. Bacteriostatic water reconstitution errors affect concentration accuracy but do not independently cause systemic GH-driven tissue changes.
CJC-1295 stimulates pituitary GH release, and Teichman et al. (2006, JCEM) confirmed it produces sustained IGF-1 elevation lasting over 6 days after a single dose in healthy adults.
Chronic IGF-1 excess is the mechanism behind acromegaly, which is clinically characterized by enlarged extremities and facial cartilage changes including the nose and ears, per Melmed (2014, NEJM).

What it may miss

It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
Compound access, legal status, and product quality still need a separate safety check.
Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

CJC-1295 stimulates pituitary GH release, and Teichman et al. (2006, JCEM) confirmed it produces sustained IGF-1 elevation lasting over 6 days after a single dose in healthy adults.
Chronic IGF-1 excess is the mechanism behind acromegaly, which is clinically characterized by enlarged extremities and facial cartilage changes including the nose and ears, per Melmed (2014, NEJM).
Cartilage growth in the nose and ears is generally irreversible once established, making early recognition of GH excess signs clinically important.
Bacteriostatic water volume errors affect dosing concentration, not whether GH stimulation occurs systemically. The two issues in this video are unrelated.
Using CJC-1295 without physician oversight and regular IGF-1 monitoring removes the primary safeguard against cumulative GH excess and its tissue effects.
Stacking CJC-1295 with a GHRP like ipamorelin amplifies GH pulse magnitude and increases the likelihood of acromegaloid side effects, a context absent from this video.
CJC-1295 is not FDA-approved for general use. Legitimate access requires a prescribing clinician, documented indication, and ongoing lab monitoring.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @yeyeneaters actually say?

The creator warned viewers not to take what sounds like CJC-1295 (transcribed here as "CGZ 125") without knowing the side effects. They described "growing pain in my hands," their nose getting bigger, and their ears getting bigger. They also mentioned not using "enough back water," which likely refers to bacteriostatic water used to reconstitute peptide vials.

To be direct: this is a short anecdotal report from someone who may be experiencing real symptoms, but the framing conflates normal growth hormone-related effects with something alarming and undisclosed. The suggestion that "not a lot of people know about this" overstates how hidden these effects are. They are documented, if not always prominently discussed in peptide communities.

Does the science back this up?

Partly, yes. CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog. It stimulates the pituitary to release growth hormone, which then drives IGF-1 production. Elevated IGF-1 is what causes soft tissue and cartilage growth, including in the hands, nose, and ears. This is not a secret side effect.

Acromegaly, the clinical condition caused by chronic excess growth hormone, is characterized by exactly these features: enlarged extremities, coarsened facial features, and jaw changes. A 2014 review by Melmed in the New England Journal of Medicine documented soft tissue and skeletal changes as core features of GH excess. The creator's described symptoms, if real, are consistent with supraphysiological GH stimulation. Whether from overdosing, extended use, or individual sensitivity is unknown from this clip.

The bacteriostatic water comment is a separate issue. Improper reconstitution does not cause acromegaly-like symptoms. That part of the video is likely unrelated to the side effects being described.

What did they get wrong (or right)?

They got the general direction right: excess GH stimulation from a GHRH analog like CJC-1295 can cause soft tissue growth in extremities and facial cartilage. That is real and worth flagging.

What they got wrong, or at least confused, is the framing that this is obscure knowledge. The FDA, endocrinology literature, and even most peptide-focused forums discuss these effects openly. They also appear to conflate the side effects of the peptide itself with a possible reconstitution error, which are unrelated issues. "Not enough back water" affects concentration and injection volume, not whether growth hormone is being overstimulated systemically.

There is also no mention of dose, frequency, or whether they combined CJC-1295 with a GHRP like ipamorelin, which is a common stack. Stacking amplifies GH pulses and would increase the likelihood of these effects. Missing that context makes the warning incomplete.

What should you actually know?

CJC-1295 is not approved by the FDA for general use. It is studied in clinical contexts, including a 2006 trial by Teichman et al. in the Journal of Clinical Endocrinology and Metabolism, which showed sustained GH and IGF-1 elevation after single doses. Sustained IGF-1 elevation is the mechanism behind soft tissue changes.

If you are using CJC-1295 through a legitimate telehealth platform with physician oversight, your provider should be monitoring IGF-1 levels and watching for signs of GH excess. If you are sourcing it elsewhere and self-administering without labs, the risks described in this video are real and not trivial. Cartilage growth in the nose and ears is not reversible once it occurs. These are not minor inconveniences.

The creator's experience, if accurately described, is a reasonable cautionary signal. But a 15-second TikTok with no dose information, no lab values, and a confused comment about reconstitution is not a substitute for medical evaluation or clinical monitoring.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Yeyeneaters · TikTok creator

111.6K views on this video

Not a lot of people know about this #fyp #cjc #research #grey #larp

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about cjc-1295 stimulates pituitary gh release,?

CJC-1295 stimulates pituitary GH release, and Teichman et al. (2006, JCEM) confirmed it produces sustained IGF-1 elevation lasting over 6 days after a single dose in healthy adults.

What does the video say about chronic igf-1 excess?

Chronic IGF-1 excess is the mechanism behind acromegaly, which is clinically characterized by enlarged extremities and facial cartilage changes including the nose and ears, per Melmed (2014, NEJM).

What does the video say about cartilage growth in the nose?

Cartilage growth in the nose and ears is generally irreversible once established, making early recognition of GH excess signs clinically important.

What does the video say about bacteriostatic water volume errors affect dosing concentration, not whether gh?

Bacteriostatic water volume errors affect dosing concentration, not whether GH stimulation occurs systemically. The two issues in this video are unrelated.

What does the video say about using cjc-1295 without physician oversight?

Using CJC-1295 without physician oversight and regular IGF-1 monitoring removes the primary safeguard against cumulative GH excess and its tissue effects.

What does the video say about stacking cjc-1295 with a ghrp like ipamorelin amplifies gh pulse?

Stacking CJC-1295 with a GHRP like ipamorelin amplifies GH pulse magnitude and increases the likelihood of acromegaloid side effects, a context absent from this video.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.